It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...

As a nurse, I’ve seen how the virus can cause serious health complications. Check out the following items to keep on hand to ...

Sinusitis, or a sinus infection, can cause a stuffy or runny nose, a decreased sense of smell, and other symptoms. You can usually manage the symptoms at home with a decongestant. The sinuses are ...

A running list of brands supporting fire relief efforts in Los Angeles. By Erin Lassner, Laurie Brookins If you purchase an independently reviewed product or service through a link on our website ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...

Fortunately, taxpayers have several avenues to address their tax liabilities and tax relief, even when immediate full payment isn't feasible. The IRS provides various programs, such as installment ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...

The nasal spray can be given to people who haven’t seen improvements in their depression after taking at least two oral medications, according to Johnson & Johnson. The main ingredient for the ...

This new treatment could help bring relief for millions of Americans struggling with depression. The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...

On Tuesday, the Food and Drug Administration (FDA) approved Johnson & Johnson’s nasal spray, Spravato (esketamine), to treat major depressive disorder. Oral antidepressants are the most common ...